This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In 2024, the FDA approved Flyrcado for patients with known or suspected coronary artery disease (CAD), delivering higher diagnostic efficacy compared to single-photon emission computed tomography (SPECT) i myocardial perfusion imaging (MPI), the predominant procedure used in nuclear cardiology today. Click here to learn more about Flyrcado.
mtaschetta-millane Mon, 07/29/2024 - 09:02 July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth. billion.
With the rise of digital health, innovative solutions are emerging that can significantly impact patient care and recovery while simultaneously addressing health equity. In 2020, she received the AHA/ASA David Sherman award for her lifetime contributions to post acute stroke care, research, training, innovation, and advocacy ([link] ).
This innovative technology maximizes operational efficiency, enhances staff expertise, and delivers better patient outcomes, making it a wise long-term investment. 2024,November 8). a huge win: CMS significantly increases Medicare payments for cardiac CT. For more information on Revolution Vibe, please visit gehealthcare.com.
In late 2023, CMS released the 2024 Medicare Physician Fee Schedule (MPFS) Final Rule, ushering in key policy changes for the Quality Payment Program (QPP). The 2024 payment adjustment is important to compensation for Medicaid services provided. Be sure to check your qualifying status using the QPP Participation Status Tool.
HIMSS 2024 will be held March 11-15 in Orlando, FL. He has 15 years’ experience with e-government development, but has found his heart is in digital health and innovation. As the first person to hold this role, Fletcher also serves as the director of the digital service at CMS, an agency team of the United States Digital Service.
As a whole, the computed tomography market size in the US in 2024 is estimated to be $2.38 billion by 2029, growing at a CAGR of 5.86% in the forecast period (2024-2029), according to a new report released by Mordor Intelligence. billion, and expected to reach $3.18 Rao, MD, FACR, from Thomas Jefferson University Hospitals.
13, 2025 Medtronic recentlyannounced that the Centers for Medicare & Medicaid Services (CMS) is opening a national coverage analysis (NCA) on renal denervation, a process that will allow the agency to review and develop a national Medicare coverage policy for renal denervation procedures for patients with hypertension. TCT 2024 4 WHO.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content